United States · FDA National Drug Code directory
Lisinopril and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43547-421_aa807721-e199-4e66-a188-a034be14f6a4
- Product NDC
- 43547-421
- Form
- TABLET
- Composition / generic term
- Lisinopril and Hydrochlorothiazide Tablets
- Labeler
- Solco Healthcare LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150312
- Source listing expiry
- 20261231
Source-listed ingredients
- LISINOPRIL — 20 mg/1
- HYDROCHLOROTHIAZIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (43547-421-10) · 43547-421-10
- 1000 TABLET in 1 BOTTLE (43547-421-11) · 43547-421-11
- 500 TABLET in 1 BOTTLE (43547-421-50) · 43547-421-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →